The COVID-19 pandemic, as we know it, has become a secondary concern. However, the virus is here to stay, says professor Krzysztof Pyrć, a virologist from the Jagiellonian University in Kraków.
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine Nuvaxovid, which is already the fifth vaccine approved for use in the EU.
Numerous European governments are considering following Austria's example, but fear of increasing vaccine hesitancy, political losses and accusations of violating human rights.
Vaccination is the most effective way to end the pandemic and get back to a normal life, says Stella Kyriakides, EU Commissioner for Health and Food Safety.
We are not homogeneous in our views, and the pandemic has also made people express their health choices in visible ways, says Pia Vuolanto, project coordinator of VAX-TRUST project.
The biggest issue is that people are scared because they do not have enough knowledge to understand how vaccines work, says Chiara Močnik Pegan from European Medical Students' Association.
The countries' vaccination schedules determine when patients should be vaccinated against a given disease and which vaccinations are compulsory for which group.
IMMUNION will contribute to and complement wider EU vaccination efforts through delivering better education to health professionals and better information to the general public.
